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Abstract 
The experiments with rats show that when administered intravenously (5 mg/kg) and 
intragastrically (5, 10, 15 and 20 mg/kg), SS-68 compound exerts an anti-
inflammatory effect (AIE) on models of acute inflammation, caused by carrageenin 
and serotonin, and exerts no AIE in case of edema induced by complete Freund‘s 
adjuvant (CFA) and histamine, except for intragastric administration at a dose of 20 
mg/kg. 
By its antiphlogogenic effect in case of carrageenin and serotonin edemas, SS-68 is 
comparable to diclofenac (5, 10 and 15 mg/kg intragastrically) and indomethacin (10 
mg kg intragastriccally), and exceeds piroxicam (20 mg/kg intragastrically). By 
reference to its therapeutic index (TI), in the first case SS-68 exceeds diclofenac, 
indomethacin and piroxicam 2.2, 15.6 and 5.6 times, and in the second case it 
exceeds them 1.8, 12.8 and 4.4 times, respectively. 
In the mouse acetic writhing test, which reflects the predominant effect on κ (kappa)-
opioid receptors, SS-68 when administered intraperitoneally at doses of 0.03, 0.06 
and 0.12 mg/kg causes a dose-dependent decrease in the number of writhes by 40.0, 
69.0 and 80.3%, respectively. Butorphanol, used for comparison in doses of 0.03, 
0.12, 0.24, 0.48 and 0.96 mg/kg, exerts a dose-dependent analgesic effect (AE), with 
the number of writhes being 41.5, 52.4, 65.3, 71.1 and 80.6%, respectively. By its 
analgesic activity and TI, SS-68 exceeds butorphanol 1.9 and 2.7 times, respectively. 
Based on the results of the docking of affinity indicators for κ1-opioid receptors of 
SS-68, butorphanol (agonist-antagonist), as well as U-50488 compounds (selective 
agonist), it was established that, in accordance with the calculated values of the 
binding constant, the affinity in relation to SS-68 was 4.53 times higher than for 
butorphanol, and when compared with U-50488 it was 2.84 times lower. The 
suggestion is that AE of SS-68, like that of butorphanol, can be linked with both 
affinity for κ1-receptors and for other types of opioid receptors (mu, delta) and κ-
receptor subtypes (κ2 or κ3). 
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Introduction  
Earlier, we have shown that SS-68 indole 
derivative has a high antiarrhythmic (in case of 
heart rhythm disorders of peripheral and central 
genesis) and anti-ischemic (antianginal) effect 
[1]. Besides, it is known that indole derivatives, 
in particular indomethacin and etodolac [2], 
have pronounced anti-inflammatory and 
analgesic properties. 
According to [3], of all opioid receptor 
subtypes, the κ(kappa)-opioid receptor system 
takes the most significant part in developing the 
aforementioned pharmacological effects of 
many substances, and κ-receptor agonists can 
potentially become promising in terms of being 
used as a base for creating new medications 
with antiarrhythmic, antianginal, anti-
inflammatory, analgesic and other effects.  
In view of the foregoing, it was of interest 
to study the anti-inflammatory and analgesic 
(realized through the impact on κ-opioid 
receptors) effect of SS-68. 
The Goal was to evaluate the anti-
inflammatory and analgesic effect of SS-68. 
 
Materials and Methods 
The SS-68 compound was synthesized at 
the Department of Natural and High Molecular 
Compounds at the Southern Federal University 
(Rostov-on-Don, Russia). 
The experiments were carried out on 87 
white non-linear male mice and 302 male rats 
weighing 22-24 g and 210-230 g, respectively. 
The animals were kept in the standard 
conditions in a vivarium in accordance with 
GOST R 50258-92. 
Studies of anti-inflammatory and analgesic 
effects were carried out in compliance with the 
―The Guidelines for Conducting Pre-clinical 
Studies of Medications‖ [4]. 
To study the effect of SS-68 on exudative 
inflammation, there were used the models of 
inflammation caused by carrageenin [5], 
serotonin, histamine and complete Freund‘s 
adjuvant [4]. Phlogogenic substances (made by 
―Sigma‖) – carrageenin (1%), serotonin (0.1%), 
histamine hydrochloride (2 mM) and CFA (0.1 
ml) were injected subplantarly into the right 
hind paw of the rats. The compound SS-68, 
water-based for injection, was injected 
intravenously (iv) into the vein of the tail and 
intragastrically (IG) once for histamine and 
serotonin-induced edemas and twice in case of 
edemas caused by carrageenin and CFA. 
Diclofenac sodium, indomethacin and 
piroxicam (tablets crushed to homogeneous 
mass in Tween-80), used as reference 
preparations, were injected ig once through the 
probe 1 hour before phlogogens. 
The volume of the paws (the right one and 
the left intact one) was measured 
oncometrically using a plethysmometer 
(―UgoBasile‖, Italy) 4 and 24 hours after 
carrageenin and CFA administration, 30 and 45 
minutes after histamine and serotonin 
administration, respectively. 
For assessing the inflammatory response of 
the paw, the following formula (1) was used: 
 
 ,           (1) 
 
where I – is an increase in paw volume 
(%); Vt – paw volume after injection of 
phlogogen (ml); and Vo – paw volume before 
phlogogone administration (ml). 
 
The therapeutic effect of SS-68 and 
reference preparations was evaluated in 
comparison with the control; the calculations 
were made by using the formula (2): 
 
,     (2) 
 
where e – are experimental animals, c – are 
control animals. 
 
In addition, the antiphlogogenic affect of 
substances was assessed by average effective 
doses (ED50) and a range of therapeutic effect – 
the therapeutic index (TI = LD50 / ED50). 
The analgesic effect was studied using 
mouse acetic writhing test. The chosen test is 
intended to study the acute visceral and deep 
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somatic pain [6, 7]. 
The SS-68 compound and butorphanol 
tartrate (JSC Moscow Pharmaceutical Factory, 
Russia), taken for comparison, both water-
based for injections, were administered to the 
animals once intraperitoneally (ip) to the right 
lower third of the abdomen in doses ranging 
from 0.03 to 0.12 mg/kg and from 0.03 to 0.96 
mg kg, respectively, 5 minutes before ip (on the 
left side) injection of 0.6% acetic acid solution 
(0.1 ml/10 g of body weight) [6]. The degree of 
analgesic effect (A) of substances was 
expressed as a percentage, using the following 
formula (3): 
 
,           (3) 
 
where Nc – is the number of writhes in the 
control group of animals, Ne – in the 
experimental group.  
 
In addition, the analgesic effect was 
evaluated by ED50 and TI. 
Besides, the κ1-opioid receptor SS-68, 
butorphanol, a partial agonist of the κ1 
receptors, and U-50488, a highly selective κ1 
receptor agonist, were docked into a specific 
binding site. The construction of 10 
conformations of each compound was carried 
out in Marvin Sketch 17.1.23 program [8]. 
These conformations were optimized in 
MOPAC2016 [9] and the best one with 
minimal energy was selected. The docking of a 
human κ1-opioid receptor (PDB code 4DJH) 
into an X-ray diffraction dimer model [10] was 
performed using AutoDock Vina 1.1.1 [11] 
(each compound was docked 5 times into each 
of the two dimer sites), along with calculating 
the minimum docking energy ΔE. The 
ensemble docking procedure is described in 
detail in [12]. 
The calculation for the docking energy ΔE 
of the binding constants K was carried out 
using the formula (4): 
,ΔE/RT-eK =           (4) 
 
where R – is gas constant equal to 8.314 
J/mol; T – temperature, the standard value in 
docking is 300 
o
K. 
Statistical processing of the data obtained 
in graded and alternative forms was carried out 
by means of computer software developed at 
the Department of Pharmacology of  Kuban 
State Medical University of the Ministry of 
Healthcare of Russia. 
 
Results and Discussion 
SS-68 compound administered iv to rats at 
a dose of  5 mg/kg caused a marked inhibition 
of exudative inflammation triggered by 
phlogogens carrageenin and serotonin, while 
inhibition of edema compared with the control 
group was 71.4 and 77.8 %, respectively (Table 
1). No inhibition of edema was observed when 
administering SS-68 in the indicated dose and 
via the above channel in cases of inflammatory 
process caused by CFA and histamine (Table 
1). 
In cases of administering ig SS-68 and 
diclofenac in doses of 5, 10 and 15 mg/kg, the 
inhibition of carrageenin and serotonin edema 
was 36.2 and 27.5, 59.0 and 52.8, 75.2 and 79.2 
for the former substance, and 24.5 and 28.4, 
52.4 and 54.3, 67.8 and 72.5% for the latter 
substance, respectively, i.e., in terms of the 
antiexudative effects of SS-68 and diclofenac 
in presence of marked phlogogens, they were 
close. It was of interest to compare the 
antiphlogogenic effect of SS-68 under the 
accepted experimental conditions with that of 
indomethacin and pyroxicam in doses of 10 and 
20 mg/kg, which, according to our data and 
literature data [13], corresponds to ED50. It was 
found that with carrageenin and serotonin 
inflammation, indomethacin and piroxicam 
caused inhibition of edema by 45.4 and 97.1, 
54.8 and 40.6%, respectively (Table 1), that is, 
the antiphlogogenic effect of these drugs was 
close to that SS-68. The exception was the 
antiexudative effect of indomethacin in 
serotonin edema, which was more significant 
than that of SS-68, as well as of diclofenac and 
piroxicam. 
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Table 1 
The impact of SS-68, diclofenac, indomethacin and piroxicam on the  
development of acute exudative edema caused by carrageenin, CFA, serotonin and histamine in 
rats (M ± m) 
 
Inflammatio
n initiator 
Substance 
under study 
No of 
animals 
Dose, 
mg/kg 
Route 
Edema increase, 
% 
Edema 
inhibition, 
% 
Carrageenin Control 8   59.7 ± 6.5  
SS-68 8 5 iv 16.9 ± 3.6*** 71.7 
10 5 ig 38.1 ± 3.1** 36.2 
10 10 ig 24.5 ± 4.1*** 59.0 
10 15 ig 14.8 ± 3.8*** 75.2 
Diclofenac 9 5 ig 45.1 ± 2.1* 24.5 
10 10 ig 28.4 ± 4.1*** 52.4 
10 15 ig 19.2 ± 3.5*** 67.8 
Indomethacin 8 10 ig 32.6 ± 5.2** 45.4 
Piroxicam 8 20 ig 27.0 ± 8.6*** 54.8 
Serotonin Control 8   78.8 ± 3.4  
SS-68 8 5 iv 17.5 ± 6.0*** 77.8 
10 5 ig 57.1 ± 4.7** 27.5 
10 10 ig 37.2 ± 4.3*** 52.8 
10 15 ig 16.4 ± 3.8*** 79.2 
Diclofenac 10 5 ig 56.4 ± 4.8** 28.4 
9 10 ig 36.0 ± 5.6*** 54.3 
10 15 ig 21.7 ± 4.2*** 72.5 
Indomethacin 8 10 ig 2.3 ± 0.9*** 97.1 
Piroxicam 8 20 ig 46.8 ± 5.8** 40.6 
CFA Control 8   147.0 ± 9.0  
SS-68 8 5 iv 154.9 ± 8.0 -5.4 
8 10 ig 138.7 ± 7.6 5.6 
10 20 ig 105.0 ± 8.2** 28.6 
Diclofenac 10 10 ig 98.6 ± 6.3*** 32.7 
Indomethacin 8 10 ig 67.7 ± 5.0*** 53.9 
Piroxicam 8 20 ig 112.6 ± 17.6 23.4 
Histamine Control 8   70.0 ± 9.7  
SS-68 8 5 iv 54.1 ± 9.2 22.7 
10 10 ig 68.3 ± 7.9 2.4 
10 20 ig 37.4 ± 4.5** 46.6 
Diclofenac 8 10 ig 29.0 ± 3.8*** 58.6 
Indomethacin 8 10 ig 40.3 ± 8.6* 42.4 
Piroxicam 8 20 ig 60.5 ± 4.7 13.6 
Note: * р< 0.05, ** p< 0.01,*** p< 0.001 compared with control 
 
To assess the antiexudative effect of SS-68 
and reference preparations, we compared their 
ED50 (calculated for SS-68 and diclofenac and 
borrowed from literature sources for piroxicam 
[13]) and TI. It turned out that by activity 
(ED50) SS-68, diclofenac and indomethacin are 
almost comparable. As for piroxicam, SS-68 
was 2.4 times more significant by this indicator 
in relation to it. By their TI in the case of 
carrageenin and serotonin inflammation, SS-68 
exceeded diclofenac, indomethacin and 
piroxicam 2.2, 15.6 and 5.1 times in the former 
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case, and 1.8, 12.8 and 4.4 times in the latter case, respectively (Table 2). 
Table 2 
Acute toxicity, anti-inflammatory effect and TI of SS-68, on carrageenan and 
 serotonin models of exudative inflammation in rats 
 
Substance LD50
1
, mg/kg 
Exudative inflammation models 
carrageenan serotonin 
ED50, mg/kg TI 
ED50, 
mg/kg 
TI 
SS-68 608.0 8.3 73.3 9.5 64.0 
Diclofenac 350.0
2
 10.4 33.7 9.6 36.5 
Indomethacin 47.0
3
 
(26.0 ’ 85.0) 
10.0 4.7 9.4 5.0 
Piroxicam 290.0
4
 
(193.0 ’ 435.0) 
20.0
4
 
(13.0 ’ 32.0) 
14.5 20 14.5 
1
 For mice via ig administration 
2
Neugodnova, O.P. et al. [14]. 
3 
Tsarichenko, G.V., Gan ina, G.A. [15]. 
4
Sigidin, Ya.A. et al. [13].  
Note: In brackets is confident limit when p=0.05. 
 
With CFA-and histamine-induced edema, 
SS-68 (iv 5 mg/kg and/or 10 mg/kg) and 
piroxicam (ig 20 mg kg) showed no statistically 
significant anti-inflammatory effect, whereas 
SS-68 (ig 20 mg/kg), diclofenac (ig 10 mg/kg) 
and indomethacin (ig 10 mg/kg) inhibited the 
edema induced by the former phlogogen by 
28.6, 32.7 and 53.9%, by the latter – by 46.6, 
58.6 and 42.4%, respectively.  
Our data on the anti-inflammatory effect of 
SS-68 in the selected models of edema 
reflecting various pathogenetic mechanisms of 
acute exudative inflammation (carrageenan 
edema simulates the prostaglandin phase of 
inflammation completed by affecting 
cyclooxygenase; serotonin and histamine 
edemas simulate the release of the marked 
biogenic amines increasing vascular 
permeability from mast cells; CFA-induced 
edema coincides with the initial phase of 
inflammation involving cytokines, in particular 
IL-1, IL-2, IL-6, IL-8, TNF-α, IFN-γ, as well as 
leukotrienes accumulated at that stage of 
arachidonic acid metabolism, which is realized 
via the 5-lipoxygenase pathway [16, 17]) to a 
certain extent attest to the ―universal‖ 
mechanism of anti-inflammatory effect of SS-
68. 
Thus, SS-68 with iv and ig administration 
can exert an anti-inflammatory (dose-
dependent in the latter administration route) 
effect on models of acute carrageenin- and 
serotonin-induced inflammation, and exerts no 
anti-inflammatory effect with CFA- and 
histamine-induced edema, except cases of ig 
administration at a dose of 20 mg/kg. 
According to antiphlogogenic activity in 
carrageenan and serotonin edema, SS-68 is 
comparable with diclofenac and indomethacin 
and exceeds piroxicam, and by TI it exceeds all 
the reference preparations. 
In the mouse acetic writhing test, which 
reflects the predominant effect on κ-receptors, 
the number of writhes in the control group of 
animals was 29.4 on average. The SS-68 
compound at doses of 0.03, 0.06 and 0.12 
mg/kg caused a dose-dependent decrease in the 
number of writhes by 40.0, 69.0 and 80.3%, 
respectively (Table 3). 
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Table 3  
Analgesic effect of SS-68 and butorphanol with ip administration  
in mouse acetic writhing test (M ± m) 
 
Substance 
No of  
animals 
Dose, 
mg/kg 
Analgesic effect 
number of writhes in relation to  
control, % 
Control 12  29.4 ± 2.8 - 
SS-68 
10 0.03 17.6 ± 2.6* 40.0 
10 0.06 9.1 ± 1.2** 69.0 
10 0.12 5.8 ± 1.1** 80.3 
Butorphanol 
10 0.03 17.2 ± 2.4* 41.5 
8 0.12 14.0 ± 1.3** 52.4 
9 0.24 10.2 ± 1.5** 65.3 
8 0.48 8.5 ± 1.6** 71.1 
10 0.96 5.7 ± 1.2** 80.6 
Note: * р< 0,01, ** p< 0,001compared with control 
 
Butorphanol, used for comparison under 
the experimental conditions, at doses of 0.03, 
0.12, 0.24, 0.48 and 0.96 mg/kg had a dose-
dependent analgesic effect, with the number of 
writhes in comparison with that in the control 
group being 41.5, 52.4, 65.3, 71.1 and 80.6%, 
respectively (Table 3). The calculation of ED50 
and TI of SS-68 and butorphanol showed that 
for the former their values are 0.038 mg/kg and 
7276.3, and for the latter – 0.072 mg/kg and 
2666.7, that is, by its analgesic effect and TI, 
SS-68 exceeds butorphanol 1.9 and 2.7 times, 
respectively (Table 4). 
Table 4 
Acute toxicity, analgesic effect and TI of SS-68 and butorphanol 
when administered ip in mouse acetic writhing test 
 
Substance 
LD50, 
mg/kg 
Analgesic effect 
ED50, mg/kg relative TI relative 
SS-68 276.5 0.038 1.9 7276.3 2.7 
Butorphanol 192.0
1
 0.072 1 2666.7 1 
1Аnisimova, V.A. et al. [18]. 
 
To confirm the agonistic effect of SS-68 on 
κ1-receptors, we compared the affinity values 
of SS-68, butorphanol, and U-50488 compound 
for these receptors, calculated basing on the 
docking results. It was found that, in 
accordance with the target value of the binding 
constant, the affinity of SS-68 for the κ1-opioid 
receptors was 4.53 higher than that of  
butorphanol, and 2.84 times lower than that of  
U-50488 (Table 5).  
Table 5  
Results of docking SS-68, butorphanol and U-50488 substance into specific binding site  
of κ1-opioid receptor 
 
Substance 
Docking energy ΔE, 
kcal/mol 
Binding constant K, nM 
SS-68 -8.60 538.1 
Butorphanol -7.70 2437.3 
U-50488 -9.20 196.5 
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It should be noted that U-50488 is more 
toxic than SS-68: when administered ip to 
mice, the LD50 of the former being 25 mg/kg 
[19], whereas for the latter – 276.5 mg/kg. 
Thus, SS-68 has an analgesic effect, 
realized through the peripheral level of 
establishing pain sensitivity through agonistic 
action on κ1-receptors. It is possible that the 
analgesic effect of SS-68, like that of  
butorphanol, can be linked to affinity for κ1-
receptors, other types of opioid receptors (mu, 
delta) and for κ-receptor subtypes (κ2 or κ3). To 
identify the possible involvement of certain 
opioid receptors in the mechanism of analgesic 
action of SS-68, additional in-depth studies are 
needed, which will make it possible to classify 
SS-68 as either selective or non-selective κ-
receptor agonist. 
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